登入
選單
返回
Google圖書搜尋
Lagged-Price Reimbursement Contracts
Angelique Acquatella
其他書名
The Impact of Medicare Part B on Pharmaceutical Price Growth
出版
National Bureau of Economic Research
, 2023
URL
http://books.google.com.hk/books?id=EoFf0AEACAAJ&hl=&source=gbs_api
註釋
We examine cost-plus lagged-price reimbursement contracts, focusing on Medicare Part B's payment for physician-administered drugs. Our theoretical model shows that lagged-price reimbursement can raise launch prices but lower prices in later periods. While previous research showed Part B increased launch prices, we estimate its effect on later prices (net of rebates). Drugs more exposed to Medicare have lower price growth. A drug with above median Part B exposure has a 10% lower price after 3 years than a below median exposure drug that launched at the same price, with a larger effect for newly approved molecules.
